Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis

• Status: Completed
• Trial end date: 2011-02-28
• Target enrollment: 0
• Participant gender: All

Summary

This non-interventional, observational study investigates the efficacy, safety and usability of methoxy polyethylene glycol epoetin beta in participants on peritoneal dialysis. Participants who were prescribed methoxy polyethylene glycol epoetin beta by their doctor and who meet the selection criteria were to be enrolled and documented in this study for a period of 9 months of treatment with methoxy polyethylene glycol epoetin beta with respect to efficacy, safety and usability.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hoffmann-La Roche
• Treatments: Epoetin Alfa

Criteria

Inclusion Criteria:

• Participants on peritoneal dialysis

• Need for Erythropoiesis Stimulating Agent (ESA) therapy

• Prescription of methoxy polyethylene glycol epoetin beta by the doctor

Exclusion Criteria:

N/A